

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.84620497 |
| 2 | drug transport (GO:0015893) | 8.34099155 |
| 3 | organic cation transport (GO:0015695) | 8.14868032 |
| 4 | phosphate ion transport (GO:0006817) | 7.65933663 |
| 5 | lysine metabolic process (GO:0006553) | 7.38403903 |
| 6 | lysine catabolic process (GO:0006554) | 7.38403903 |
| 7 | excretion (GO:0007588) | 6.87086752 |
| 8 | renal absorption (GO:0070293) | 6.68158202 |
| 9 | drug catabolic process (GO:0042737) | 6.64903153 |
| 10 | exogenous drug catabolic process (GO:0042738) | 6.60840580 |
| 11 | quaternary ammonium group transport (GO:0015697) | 6.32597519 |
| 12 | glyoxylate metabolic process (GO:0046487) | 6.07023562 |
| 13 | metanephric tubule development (GO:0072170) | 6.03776161 |
| 14 | metanephric nephron tubule development (GO:0072234) | 6.03776161 |
| 15 | response to mercury ion (GO:0046689) | 5.99160405 |
| 16 | phosphate ion transmembrane transport (GO:0035435) | 5.97759701 |
| 17 | phosphate ion homeostasis (GO:0055062) | 5.94460478 |
| 18 | trivalent inorganic anion homeostasis (GO:0072506) | 5.94460478 |
| 19 | toxin transport (GO:1901998) | 5.76716349 |
| 20 | vitamin D metabolic process (GO:0042359) | 5.74600318 |
| 21 | metanephric nephron epithelium development (GO:0072243) | 5.60957253 |
| 22 | metanephric epithelium development (GO:0072207) | 5.36950444 |
| 23 | tricarboxylic acid metabolic process (GO:0072350) | 5.31046801 |
| 24 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.21175098 |
| 25 | glycoside metabolic process (GO:0016137) | 5.20038401 |
| 26 | cysteine metabolic process (GO:0006534) | 5.16469651 |
| 27 | DNA deamination (GO:0045006) | 5.02800528 |
| 28 | short-chain fatty acid metabolic process (GO:0046459) | 4.84557938 |
| 29 | branched-chain amino acid metabolic process (GO:0009081) | 4.82232570 |
| 30 | nephron tubule development (GO:0072080) | 4.79306753 |
| 31 | homocysteine metabolic process (GO:0050667) | 4.74714558 |
| 32 | aspartate family amino acid catabolic process (GO:0009068) | 4.73425012 |
| 33 | glutathione biosynthetic process (GO:0006750) | 4.51946261 |
| 34 | valine metabolic process (GO:0006573) | 4.45975571 |
| 35 | behavioral response to nicotine (GO:0035095) | 4.44577999 |
| 36 | fucose catabolic process (GO:0019317) | 4.44069867 |
| 37 | L-fucose metabolic process (GO:0042354) | 4.44069867 |
| 38 | L-fucose catabolic process (GO:0042355) | 4.44069867 |
| 39 | tryptophan catabolic process (GO:0006569) | 4.32714611 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 4.32714611 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 4.32714611 |
| 42 | amino-acid betaine transport (GO:0015838) | 4.30798353 |
| 43 | carnitine transport (GO:0015879) | 4.30798353 |
| 44 | renal tubule development (GO:0061326) | 4.29199241 |
| 45 | aromatic amino acid family catabolic process (GO:0009074) | 4.23681874 |
| 46 | proline metabolic process (GO:0006560) | 4.18946905 |
| 47 | nephron tubule morphogenesis (GO:0072078) | 4.16839578 |
| 48 | nephron epithelium morphogenesis (GO:0072088) | 4.16839578 |
| 49 | modified amino acid transport (GO:0072337) | 4.16278127 |
| 50 | oligosaccharide catabolic process (GO:0009313) | 4.14317925 |
| 51 | nephron epithelium development (GO:0072009) | 4.06777607 |
| 52 | respiratory chain complex IV assembly (GO:0008535) | 4.06190497 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.03495791 |
| 54 | tryptophan metabolic process (GO:0006568) | 4.03215943 |
| 55 | polyol transport (GO:0015791) | 4.03062673 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.00742880 |
| 57 | L-phenylalanine metabolic process (GO:0006558) | 4.00742880 |
| 58 | response to pheromone (GO:0019236) | 3.99224974 |
| 59 | fructose metabolic process (GO:0006000) | 3.97037346 |
| 60 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.97021890 |
| 61 | L-phenylalanine catabolic process (GO:0006559) | 3.94792235 |
| 62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.94792235 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 3.93951502 |
| 64 | branched-chain amino acid catabolic process (GO:0009083) | 3.91944496 |
| 65 | sodium-independent organic anion transport (GO:0043252) | 3.86567518 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 3.86374032 |
| 67 | platelet dense granule organization (GO:0060155) | 3.83486701 |
| 68 | amino-acid betaine metabolic process (GO:0006577) | 3.82730232 |
| 69 | peptide biosynthetic process (GO:0043043) | 3.78114587 |
| 70 | protein complex biogenesis (GO:0070271) | 3.77151999 |
| 71 | response to parathyroid hormone (GO:0071107) | 3.70931064 |
| 72 | negative regulation of mast cell activation (GO:0033004) | 3.68391673 |
| 73 | positive regulation of prostaglandin secretion (GO:0032308) | 3.66200586 |
| 74 | sulfur compound transport (GO:0072348) | 3.65703698 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.64722464 |
| 76 | carnitine metabolic process (GO:0009437) | 3.64107415 |
| 77 | fatty acid beta-oxidation (GO:0006635) | 3.64065005 |
| 78 | ubiquinone biosynthetic process (GO:0006744) | 3.61636647 |
| 79 | renal tubule morphogenesis (GO:0061333) | 3.60809374 |
| 80 | kynurenine metabolic process (GO:0070189) | 3.56964676 |
| 81 | cytochrome complex assembly (GO:0017004) | 3.56190727 |
| 82 | protein-cofactor linkage (GO:0018065) | 3.54795443 |
| 83 | 2-oxoglutarate metabolic process (GO:0006103) | 3.52975843 |
| 84 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.52871247 |
| 85 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.52744924 |
| 86 | NADH dehydrogenase complex assembly (GO:0010257) | 3.52744924 |
| 87 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.52744924 |
| 88 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.52079324 |
| 89 | piRNA metabolic process (GO:0034587) | 3.51679850 |
| 90 | indole-containing compound metabolic process (GO:0042430) | 3.50618530 |
| 91 | negative regulation of telomere maintenance (GO:0032205) | 3.49020392 |
| 92 | sodium ion transport (GO:0006814) | 3.48999694 |
| 93 | response to growth hormone (GO:0060416) | 3.47591505 |
| 94 | peptide catabolic process (GO:0043171) | 3.46931768 |
| 95 | ketone body metabolic process (GO:1902224) | 3.46058475 |
| 96 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.43923757 |
| 97 | cellular response to vitamin D (GO:0071305) | 3.40472994 |
| 98 | S-adenosylmethionine metabolic process (GO:0046500) | 3.39186075 |
| 99 | glomerular basement membrane development (GO:0032836) | 3.38632728 |
| 100 | response to magnesium ion (GO:0032026) | 3.38629021 |
| 101 | surfactant homeostasis (GO:0043129) | 3.37657316 |
| 102 | peptidyl-histidine modification (GO:0018202) | 3.37000269 |
| 103 | positive regulation of fatty acid transport (GO:2000193) | 3.35030445 |
| 104 | amino acid salvage (GO:0043102) | 3.35024266 |
| 105 | L-methionine salvage (GO:0071267) | 3.35024266 |
| 106 | L-methionine biosynthetic process (GO:0071265) | 3.35024266 |
| 107 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.34479643 |
| 108 | fatty acid oxidation (GO:0019395) | 3.33986460 |
| 109 | pseudouridine synthesis (GO:0001522) | 3.33012110 |
| 110 | response to phenylpropanoid (GO:0080184) | 3.30396272 |
| 111 | lipid oxidation (GO:0034440) | 3.29138847 |
| 112 | response to lead ion (GO:0010288) | 3.27205163 |
| 113 | vitamin catabolic process (GO:0009111) | 3.27075155 |
| 114 | fat-soluble vitamin catabolic process (GO:0042363) | 3.27075155 |
| 115 | ubiquinone metabolic process (GO:0006743) | 3.26253748 |
| 116 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.25004148 |
| 117 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.23440984 |
| 118 | acetyl-CoA metabolic process (GO:0006084) | 3.23390695 |
| 119 | sulfate transmembrane transport (GO:1902358) | 3.22812343 |
| 120 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.22368745 |
| 121 | detection of light stimulus involved in visual perception (GO:0050908) | 3.22368745 |
| 122 | response to thyroid hormone (GO:0097066) | 3.22257731 |
| 123 | cellular ketone body metabolic process (GO:0046950) | 3.20980690 |
| 124 | polyol catabolic process (GO:0046174) | 3.16492851 |
| 125 | NADH metabolic process (GO:0006734) | 3.15949822 |
| 126 | glutathione metabolic process (GO:0006749) | 3.15695016 |
| 127 | protein polyglutamylation (GO:0018095) | 3.15193296 |
| 128 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.15098327 |
| 129 | bone remodeling (GO:0046849) | 3.14443731 |
| 130 | regulation of cilium movement (GO:0003352) | 3.12880800 |
| 131 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.10551662 |
| 132 | cellular amino acid catabolic process (GO:0009063) | 3.10402492 |
| 133 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.09157799 |
| 134 | alpha-amino acid catabolic process (GO:1901606) | 3.07369259 |
| 135 | cobalamin metabolic process (GO:0009235) | 3.07144058 |
| 136 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.06928193 |
| 137 | aromatic amino acid family metabolic process (GO:0009072) | 3.06879019 |
| 138 | indolalkylamine metabolic process (GO:0006586) | 3.05488460 |
| 139 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.02273961 |
| 140 | ATP synthesis coupled proton transport (GO:0015986) | 3.02273961 |
| 141 | positive regulation of icosanoid secretion (GO:0032305) | 3.01481520 |
| 142 | axoneme assembly (GO:0035082) | 2.95752459 |
| 143 | mannosylation (GO:0097502) | 2.94887055 |
| 144 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.91970294 |
| 145 | positive regulation of defense response to virus by host (GO:0002230) | 2.91490919 |
| 146 | methionine biosynthetic process (GO:0009086) | 2.88483083 |
| 147 | proteasome assembly (GO:0043248) | 2.88290633 |
| 148 | auditory receptor cell stereocilium organization (GO:0060088) | 2.86512744 |
| 149 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.84585734 |
| 150 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.84585734 |
| 151 | cellular biogenic amine catabolic process (GO:0042402) | 2.82736646 |
| 152 | amine catabolic process (GO:0009310) | 2.82736646 |
| 153 | regulation of prostaglandin secretion (GO:0032306) | 2.81533870 |
| 154 | quinone biosynthetic process (GO:1901663) | 2.79727016 |
| 155 | replication fork processing (GO:0031297) | 2.74236250 |
| 156 | cellular response to ATP (GO:0071318) | 2.74098845 |
| 157 | gamma-aminobutyric acid transport (GO:0015812) | 2.72919323 |
| 158 | iron-sulfur cluster assembly (GO:0016226) | 2.72563032 |
| 159 | metallo-sulfur cluster assembly (GO:0031163) | 2.72563032 |
| 160 | cornea development in camera-type eye (GO:0061303) | 2.72354267 |
| 161 | kidney morphogenesis (GO:0060993) | 2.65977710 |
| 162 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.64469386 |
| 163 | tRNA processing (GO:0008033) | 2.62565778 |
| 164 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.61467061 |
| 165 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.61201537 |
| 166 | regulation of action potential (GO:0098900) | 2.60881308 |
| 167 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.60402353 |
| 168 | anterograde synaptic vesicle transport (GO:0048490) | 2.60334070 |
| 169 | protein K6-linked ubiquitination (GO:0085020) | 2.59013963 |
| 170 | nonmotile primary cilium assembly (GO:0035058) | 2.57058683 |
| 171 | epithelial cilium movement (GO:0003351) | 2.51772762 |
| 172 | DNA methylation involved in gamete generation (GO:0043046) | 2.50784302 |
| 173 | GPI anchor metabolic process (GO:0006505) | 2.49708385 |
| 174 | electron transport chain (GO:0022900) | 2.49441358 |
| 175 | DNA double-strand break processing (GO:0000729) | 2.49076142 |
| 176 | maturation of 5.8S rRNA (GO:0000460) | 2.47227015 |
| 177 | multicellular organism reproduction (GO:0032504) | 2.46875078 |
| 178 | C-terminal protein lipidation (GO:0006501) | 2.46405322 |
| 179 | male meiosis I (GO:0007141) | 2.45548371 |
| 180 | respiratory electron transport chain (GO:0022904) | 2.44205125 |
| 181 | cilium morphogenesis (GO:0060271) | 2.43592132 |
| 182 | cell wall macromolecule metabolic process (GO:0044036) | 2.43444884 |
| 183 | termination of RNA polymerase III transcription (GO:0006386) | 2.41208281 |
| 184 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.41208281 |
| 185 | C-terminal protein amino acid modification (GO:0018410) | 2.40599888 |
| 186 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.38162200 |
| 187 | photoreceptor cell development (GO:0042461) | 2.37901036 |
| 188 | inositol phosphate catabolic process (GO:0071545) | 2.36785665 |
| 189 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.35626710 |
| 190 | aminoglycoside antibiotic metabolic process (GO:0030647) | 12.2657251 |
| 191 | urate metabolic process (GO:0046415) | 10.1200788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ZNF274_21170338_ChIP-Seq_K562_Hela | 4.09772829 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.22624630 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.94962501 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.85104200 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.80901145 |
| 6 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.63871823 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.52673158 |
| 8 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.46836626 |
| 9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.45960001 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20509470 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.20406743 |
| 12 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.20045141 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.16441322 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.13091558 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09724387 |
| 16 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.06243609 |
| 17 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.04973078 |
| 18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.99273111 |
| 19 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.97928249 |
| 20 | FUS_26573619_Chip-Seq_HEK293_Human | 1.95342854 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 1.94598088 |
| 22 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90383490 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.89344072 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.86436083 |
| 25 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.84947362 |
| 26 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.80942295 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.80842289 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.73774161 |
| 29 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73247600 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72928122 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72659215 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72134982 |
| 33 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.71308518 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68203623 |
| 35 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68089390 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67525162 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62228875 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61285568 |
| 39 | RXR_22108803_ChIP-Seq_LS180_Human | 1.58579214 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.57948388 |
| 41 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.57318292 |
| 42 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.55010119 |
| 43 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.53398834 |
| 44 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.53239771 |
| 45 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.52421787 |
| 46 | AR_20517297_ChIP-Seq_VCAP_Human | 1.52272946 |
| 47 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49558598 |
| 48 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.49108939 |
| 49 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.49108939 |
| 50 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.46959573 |
| 51 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.46629824 |
| 52 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.46343486 |
| 53 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44902322 |
| 54 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.44533972 |
| 55 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42894094 |
| 56 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42894094 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.42317380 |
| 58 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.41647708 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.41647708 |
| 60 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40405754 |
| 61 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.40261542 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39647882 |
| 63 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.37452326 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36421247 |
| 65 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.36392004 |
| 66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.36052670 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.33873534 |
| 68 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.32674151 |
| 69 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.31862217 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.30804104 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30378646 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.30319511 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30128935 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30089484 |
| 75 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.29814882 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29559507 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29490189 |
| 78 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28886100 |
| 79 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28730086 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.28209872 |
| 81 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24869891 |
| 82 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.23602328 |
| 83 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.23069157 |
| 84 | GATA3_26560356_Chip-Seq_TH2_Human | 1.22945030 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22756413 |
| 86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22209901 |
| 87 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22198130 |
| 88 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21762073 |
| 89 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.21452971 |
| 90 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.20434426 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20278348 |
| 92 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19350825 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19261222 |
| 94 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.18821768 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18136457 |
| 96 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17913626 |
| 97 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17822078 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.16831981 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16771791 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.15986981 |
| 101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.15347563 |
| 102 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.15327219 |
| 103 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14464847 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14291422 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14245192 |
| 106 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.14229207 |
| 107 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13667554 |
| 108 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12902883 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12807169 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11696923 |
| 111 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11299390 |
| 112 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10706206 |
| 113 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.10664677 |
| 114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10290330 |
| 115 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.09496712 |
| 116 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08845628 |
| 117 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08845628 |
| 118 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.08672617 |
| 119 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.08180055 |
| 120 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08164409 |
| 121 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.07912613 |
| 122 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07165027 |
| 123 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06559449 |
| 124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06478073 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.05734126 |
| 126 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05321118 |
| 127 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.04822734 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.03877754 |
| 129 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03143525 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01448365 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01315379 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00656073 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00656073 |
| 134 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99984788 |
| 135 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99975416 |
| 136 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99934486 |
| 137 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99770211 |
| 138 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99435645 |
| 139 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.99263419 |
| 140 | P300_19829295_ChIP-Seq_ESCs_Human | 0.98778124 |
| 141 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.98358350 |
| 142 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98125461 |
| 143 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97817451 |
| 144 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97817451 |
| 145 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97663182 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97107249 |
| 147 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.95067768 |
| 148 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94938909 |
| 149 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94929049 |
| 150 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.94758983 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94062874 |
| 152 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92828206 |
| 153 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92818784 |
| 154 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92701669 |
| 155 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92542572 |
| 156 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.92198671 |
| 157 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91653276 |
| 158 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91311068 |
| 159 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91299650 |
| 160 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.90805326 |
| 161 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.90349606 |
| 162 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89144936 |
| 163 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89137028 |
| 164 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88995872 |
| 165 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88810703 |
| 166 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88778466 |
| 167 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.88271464 |
| 168 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87045140 |
| 169 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.86722963 |
| 170 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.85975136 |
| 171 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85268387 |
| 172 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.85118019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 7.45943039 |
| 2 | MP0005360_urolithiasis | 6.61329727 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 5.13765269 |
| 4 | MP0005332_abnormal_amino_acid | 4.77093784 |
| 5 | MP0003195_calcinosis | 4.49470671 |
| 6 | MP0001765_abnormal_ion_homeostasis | 4.41052124 |
| 7 | MP0009643_abnormal_urine_homeostasis | 4.14029735 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 4.08056980 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.60797410 |
| 10 | MP0001756_abnormal_urination | 3.41434000 |
| 11 | MP0002136_abnormal_kidney_physiology | 3.40798677 |
| 12 | MP0005636_abnormal_mineral_homeostasis | 3.33761744 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 3.13776836 |
| 14 | MP0003878_abnormal_ear_physiology | 3.13776836 |
| 15 | MP0005646_abnormal_pituitary_gland | 3.08284217 |
| 16 | MP0001958_emphysema | 2.60710009 |
| 17 | MP0002102_abnormal_ear_morphology | 2.56376313 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.47501246 |
| 19 | MP0005551_abnormal_eye_electrophysiolog | 2.38533863 |
| 20 | MP0003252_abnormal_bile_duct | 2.36646799 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.33618936 |
| 22 | MP0008961_abnormal_basal_metabolism | 2.09578869 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.08719614 |
| 24 | MP0004885_abnormal_endolymph | 2.08349969 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.99799282 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.99467760 |
| 27 | MP0002736_abnormal_nociception_after | 1.88712134 |
| 28 | MP0003186_abnormal_redox_activity | 1.82058178 |
| 29 | MP0006072_abnormal_retinal_apoptosis | 1.81405749 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.81098733 |
| 31 | MP0005365_abnormal_bile_salt | 1.73074959 |
| 32 | MP0009046_muscle_twitch | 1.71699335 |
| 33 | MP0000230_abnormal_systemic_arterial | 1.69202512 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.64550574 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.63807962 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.63610276 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.62961589 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.62236988 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.61262360 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.59240263 |
| 41 | MP0000538_abnormal_urinary_bladder | 1.59152525 |
| 42 | MP0005253_abnormal_eye_physiology | 1.58868168 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.57251711 |
| 44 | MP0005451_abnormal_body_composition | 1.56422314 |
| 45 | MP0009745_abnormal_behavioral_response | 1.51942759 |
| 46 | MP0002272_abnormal_nervous_system | 1.47398933 |
| 47 | MP0004142_abnormal_muscle_tone | 1.46708495 |
| 48 | MP0002928_abnormal_bile_duct | 1.44986515 |
| 49 | MP0002653_abnormal_ependyma_morphology | 1.44476366 |
| 50 | MP0000427_abnormal_hair_cycle | 1.43358071 |
| 51 | MP0003786_premature_aging | 1.39555687 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39189641 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.33093771 |
| 54 | MP0003011_delayed_dark_adaptation | 1.32204510 |
| 55 | MP0002135_abnormal_kidney_morphology | 1.31920649 |
| 56 | MP0002168_other_aberrant_phenotype | 1.31901324 |
| 57 | MP0005670_abnormal_white_adipose | 1.30388932 |
| 58 | MP0005671_abnormal_response_to | 1.28258424 |
| 59 | MP0001486_abnormal_startle_reflex | 1.26769029 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.25654691 |
| 61 | MP0003880_abnormal_central_pattern | 1.23355998 |
| 62 | MP0008058_abnormal_DNA_repair | 1.22262212 |
| 63 | MP0001984_abnormal_olfaction | 1.21521550 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.21019025 |
| 65 | MP0005389_reproductive_system_phenotype | 1.19672029 |
| 66 | MP0002938_white_spotting | 1.17146380 |
| 67 | MP0004133_heterotaxia | 1.15809481 |
| 68 | MP0009764_decreased_sensitivity_to | 1.13530855 |
| 69 | MP0003787_abnormal_imprinting | 1.13389751 |
| 70 | MP0003136_yellow_coat_color | 1.09691123 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 1.08592928 |
| 72 | MP0005319_abnormal_enzyme/_coenzyme | 1.07707878 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 1.05971381 |
| 74 | MP0001970_abnormal_pain_threshold | 1.04815842 |
| 75 | MP0004742_abnormal_vestibular_system | 1.04324733 |
| 76 | MP0005535_abnormal_body_temperature | 1.03641741 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.03142298 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 1.03004679 |
| 79 | MP0002163_abnormal_gland_morphology | 1.01095035 |
| 80 | MP0002733_abnormal_thermal_nociception | 1.00766412 |
| 81 | MP0002160_abnormal_reproductive_system | 0.99577610 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.99304275 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.98005148 |
| 84 | MP0005195_abnormal_posterior_eye | 0.96652159 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.96278009 |
| 86 | MP0001502_abnormal_circadian_rhythm | 0.95827055 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.95009082 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 0.94284458 |
| 89 | MP0002095_abnormal_skin_pigmentation | 0.94008361 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 0.92370456 |
| 91 | MP0000647_abnormal_sebaceous_gland | 0.92319941 |
| 92 | MP0002064_seizures | 0.92083712 |
| 93 | MP0002735_abnormal_chemical_nociception | 0.91961303 |
| 94 | MP0008995_early_reproductive_senescence | 0.89917665 |
| 95 | MP0003646_muscle_fatigue | 0.89578950 |
| 96 | MP0005410_abnormal_fertilization | 0.89241099 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.88275013 |
| 98 | MP0001905_abnormal_dopamine_level | 0.87929908 |
| 99 | MP0001919_abnormal_reproductive_system | 0.87927877 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.87385151 |
| 101 | MP0000678_abnormal_parathyroid_gland | 0.87152250 |
| 102 | MP0005379_endocrine/exocrine_gland_phen | 0.86728669 |
| 103 | MP0006036_abnormal_mitochondrial_physio | 0.84689750 |
| 104 | MP0001324_abnormal_eye_pigmentation | 0.84608775 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.84191103 |
| 106 | MP0004147_increased_porphyrin_level | 0.81571652 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.81430202 |
| 108 | MP0003718_maternal_effect | 0.81312880 |
| 109 | MP0002557_abnormal_social/conspecific_i | 0.80053012 |
| 110 | MP0003724_increased_susceptibility_to | 0.77632240 |
| 111 | MP0002067_abnormal_sensory_capabilities | 0.75174862 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.75007869 |
| 113 | MP0008789_abnormal_olfactory_epithelium | 0.74819504 |
| 114 | MP0000383_abnormal_hair_follicle | 0.73670661 |
| 115 | MP0005666_abnormal_adipose_tissue | 0.72591887 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.72387526 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.70559630 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.69944883 |
| 119 | MP0002229_neurodegeneration | 0.69446462 |
| 120 | MP0001764_abnormal_homeostasis | 0.67251847 |
| 121 | MP0005395_other_phenotype | 0.65004962 |
| 122 | MP0002115_abnormal_skeleton_extremities | 0.62518102 |
| 123 | MP0003879_abnormal_hair_cell | 0.62486256 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.62355463 |
| 125 | MP0003795_abnormal_bone_structure | 0.61031763 |
| 126 | MP0005165_increased_susceptibility_to | 0.60071482 |
| 127 | MP0004484_altered_response_of | 0.60006552 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.59213618 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.59007009 |
| 130 | MP0008469_abnormal_protein_level | 0.58461546 |
| 131 | MP0003959_abnormal_lean_body | 0.56741358 |
| 132 | MP0002118_abnormal_lipid_homeostasis | 0.56501927 |
| 133 | MP0008872_abnormal_physiological_respon | 0.56347406 |
| 134 | MP0005310_abnormal_salivary_gland | 0.55821893 |
| 135 | MP0001661_extended_life_span | 0.55623292 |
| 136 | MP0004264_abnormal_extraembryonic_tissu | 0.54426126 |
| 137 | MP0000026_abnormal_inner_ear | 0.49265647 |
| 138 | MP0003315_abnormal_perineum_morphology | 0.45744332 |
| 139 | MP0005408_hypopigmentation | 0.45543178 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.44545122 |
| 141 | MP0004272_abnormal_basement_membrane | 0.44144197 |
| 142 | MP0005220_abnormal_exocrine_pancreas | 0.44137647 |
| 143 | MP0000371_diluted_coat_color | 0.43828639 |
| 144 | MP0001666_abnormal_nutrient_absorption | 0.43292112 |
| 145 | MP0000163_abnormal_cartilage_morphology | 0.41541173 |
| 146 | MP0005166_decreased_susceptibility_to | 0.41482623 |
| 147 | MP0001663_abnormal_digestive_system | 0.41432807 |
| 148 | MP0000534_abnormal_ureter_morphology | 0.41362665 |
| 149 | MP0003953_abnormal_hormone_level | 0.40736898 |
| 150 | MP0003075_altered_response_to | 0.39241095 |
| 151 | MP0003183_abnormal_peptide_metabolism | 0.38467962 |
| 152 | MP0004782_abnormal_surfactant_physiolog | 0.38411897 |
| 153 | MP0002113_abnormal_skeleton_development | 0.37922223 |
| 154 | MP0004858_abnormal_nervous_system | 0.37401236 |
| 155 | MP0005595_abnormal_vascular_smooth | 0.35102252 |
| 156 | MP0001664_abnormal_digestion | 0.34683601 |
| 157 | MP0008775_abnormal_heart_ventricle | 0.34464238 |
| 158 | MP0001270_distended_abdomen | 0.33928624 |
| 159 | MP0001845_abnormal_inflammatory_respons | 0.33069105 |
| 160 | MP0002098_abnormal_vibrissa_morphology | 0.32605146 |
| 161 | MP0002972_abnormal_cardiac_muscle | 0.32237287 |
| 162 | MP0005167_abnormal_blood-brain_barrier | 0.31993935 |
| 163 | MP0008260_abnormal_autophagy | 0.31883961 |
| 164 | MP0008004_abnormal_stomach_pH | 0.31881439 |
| 165 | MP0003941_abnormal_skin_development | 0.31538830 |
| 166 | MP0005501_abnormal_skin_physiology | 0.30958697 |
| 167 | MP0002796_impaired_skin_barrier | 0.29125379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 9.80442398 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 8.81366154 |
| 3 | Hypomagnesemia (HP:0002917) | 8.15584559 |
| 4 | Metabolic alkalosis (HP:0200114) | 8.03614811 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.55555848 |
| 6 | Polyuria (HP:0000103) | 7.25992803 |
| 7 | Abnormality of chloride homeostasis (HP:0011422) | 7.01105987 |
| 8 | Abnormality of magnesium homeostasis (HP:0004921) | 6.88842449 |
| 9 | Abnormal urine output (HP:0012590) | 6.69135255 |
| 10 | Abnormality of renal excretion (HP:0011036) | 6.39129297 |
| 11 | Polydipsia (HP:0001959) | 6.23737440 |
| 12 | Abnormal drinking behavior (HP:0030082) | 6.23737440 |
| 13 | Tetany (HP:0001281) | 6.22891652 |
| 14 | Gout (HP:0001997) | 6.17242003 |
| 15 | Abnormality of renin-angiotensin system (HP:0000847) | 5.96704368 |
| 16 | Alkalosis (HP:0001948) | 5.57700784 |
| 17 | Hyperaldosteronism (HP:0000859) | 5.20867699 |
| 18 | Renal salt wasting (HP:0000127) | 4.97902283 |
| 19 | Proximal tubulopathy (HP:0000114) | 4.74198311 |
| 20 | Hypokalemia (HP:0002900) | 4.46401193 |
| 21 | Pancreatic cysts (HP:0001737) | 4.44538522 |
| 22 | Increased purine levels (HP:0004368) | 4.41897914 |
| 23 | Hyperuricemia (HP:0002149) | 4.41897914 |
| 24 | Type II lissencephaly (HP:0007260) | 4.19427307 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.06750659 |
| 26 | Abnormality of potassium homeostasis (HP:0011042) | 3.83667435 |
| 27 | Abnormality of purine metabolism (HP:0004352) | 3.80747262 |
| 28 | Hyperglycinuria (HP:0003108) | 3.79579669 |
| 29 | Hypercalciuria (HP:0002150) | 3.78919967 |
| 30 | Pancreatic fibrosis (HP:0100732) | 3.75496913 |
| 31 | Generalized aminoaciduria (HP:0002909) | 3.63910141 |
| 32 | True hermaphroditism (HP:0010459) | 3.62207624 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 3.62120299 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 3.62120299 |
| 35 | Renal tubular acidosis (HP:0001947) | 3.38562909 |
| 36 | Abolished electroretinogram (ERG) (HP:0000550) | 3.31331623 |
| 37 | Congenital stationary night blindness (HP:0007642) | 3.27002377 |
| 38 | Nephronophthisis (HP:0000090) | 3.17280819 |
| 39 | Abnormality of the renal medulla (HP:0100957) | 3.16315588 |
| 40 | Cerebellar dysplasia (HP:0007033) | 3.15184886 |
| 41 | Glycosuria (HP:0003076) | 3.11266072 |
| 42 | Abnormality of urine glucose concentration (HP:0011016) | 3.11266072 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 3.03371548 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.03371548 |
| 45 | Hydroxyprolinuria (HP:0003080) | 2.94843207 |
| 46 | Abnormality of proline metabolism (HP:0010907) | 2.94843207 |
| 47 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.93579317 |
| 48 | Nephrocalcinosis (HP:0000121) | 2.90626416 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86956916 |
| 50 | Ketoacidosis (HP:0001993) | 2.79947448 |
| 51 | Delayed epiphyseal ossification (HP:0002663) | 2.78741529 |
| 52 | Acute necrotizing encephalopathy (HP:0006965) | 2.78124139 |
| 53 | Abnormal urine phosphate concentration (HP:0012599) | 2.71963967 |
| 54 | Increased CSF lactate (HP:0002490) | 2.71796092 |
| 55 | Hyperphosphaturia (HP:0003109) | 2.70696575 |
| 56 | Retinal dysplasia (HP:0007973) | 2.68229065 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.68118345 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66602911 |
| 59 | Vascular calcification (HP:0004934) | 2.65776477 |
| 60 | Mitochondrial inheritance (HP:0001427) | 2.62522379 |
| 61 | Abnormality of alanine metabolism (HP:0010916) | 2.60147432 |
| 62 | Hyperalaninemia (HP:0003348) | 2.60147432 |
| 63 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.60147432 |
| 64 | Hypophosphatemia (HP:0002148) | 2.57984187 |
| 65 | Attenuation of retinal blood vessels (HP:0007843) | 2.55892889 |
| 66 | Hyponatremia (HP:0002902) | 2.55824387 |
| 67 | Cystic liver disease (HP:0006706) | 2.55653903 |
| 68 | Renal cortical cysts (HP:0000803) | 2.53017964 |
| 69 | Abnormality of sodium homeostasis (HP:0010931) | 2.52218714 |
| 70 | Tubular atrophy (HP:0000092) | 2.50400712 |
| 71 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.50094837 |
| 72 | Abnormality of renal resorption (HP:0011038) | 2.46410497 |
| 73 | Progressive macrocephaly (HP:0004481) | 2.45345352 |
| 74 | Chondrocalcinosis (HP:0000934) | 2.44843815 |
| 75 | Pendular nystagmus (HP:0012043) | 2.44565743 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.43146717 |
| 77 | Acute encephalopathy (HP:0006846) | 2.42423866 |
| 78 | Abnormality of Sharpey fibers (HP:0100685) | 2.39496633 |
| 79 | Rickets (HP:0002748) | 2.36380997 |
| 80 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.36055289 |
| 81 | Dehydration (HP:0001944) | 2.34760662 |
| 82 | Cardiovascular calcification (HP:0011915) | 2.34112338 |
| 83 | Ketosis (HP:0001946) | 2.33422134 |
| 84 | Nephrolithiasis (HP:0000787) | 2.33421471 |
| 85 | Lipid accumulation in hepatocytes (HP:0006561) | 2.30522394 |
| 86 | Decreased central vision (HP:0007663) | 2.30118438 |
| 87 | Widely patent fontanelles and sutures (HP:0004492) | 2.29291668 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 2.28966719 |
| 89 | Severe muscular hypotonia (HP:0006829) | 2.27784474 |
| 90 | Enlarged kidneys (HP:0000105) | 2.27732764 |
| 91 | Adrenal overactivity (HP:0002717) | 2.27111823 |
| 92 | Chronic hepatic failure (HP:0100626) | 2.23639483 |
| 93 | Hepatic necrosis (HP:0002605) | 2.21502562 |
| 94 | Generalized muscle weakness (HP:0003324) | 2.19867719 |
| 95 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.18257228 |
| 96 | Metaphyseal cupping (HP:0003021) | 2.18022862 |
| 97 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.16950508 |
| 98 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16215179 |
| 99 | Abnormal biliary tract physiology (HP:0012439) | 2.15377815 |
| 100 | Bile duct proliferation (HP:0001408) | 2.15377815 |
| 101 | Abnormality of the pons (HP:0007361) | 2.12573146 |
| 102 | Hypoplasia of the pons (HP:0012110) | 2.11959252 |
| 103 | Hepatocellular necrosis (HP:0001404) | 2.11755734 |
| 104 | Sclerocornea (HP:0000647) | 2.10396436 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09906612 |
| 106 | Renal tubular dysfunction (HP:0000124) | 2.06889060 |
| 107 | Glomerulosclerosis (HP:0000096) | 2.06420747 |
| 108 | Congenital hepatic fibrosis (HP:0002612) | 2.06339803 |
| 109 | Hyperglycinemia (HP:0002154) | 2.05229355 |
| 110 | Keratoconus (HP:0000563) | 2.03613116 |
| 111 | Increased corneal curvature (HP:0100692) | 2.03613116 |
| 112 | Hypothermia (HP:0002045) | 2.03296743 |
| 113 | Decreased circulating renin level (HP:0003351) | 2.02124911 |
| 114 | Lissencephaly (HP:0001339) | 2.02048470 |
| 115 | Tubulointerstitial fibrosis (HP:0005576) | 2.01260868 |
| 116 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.01217732 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.97388266 |
| 118 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97022972 |
| 119 | Furrowed tongue (HP:0000221) | 1.96515728 |
| 120 | Hyperventilation (HP:0002883) | 1.96347987 |
| 121 | Metaphyseal dysplasia (HP:0100255) | 1.96142820 |
| 122 | Increased serum lactate (HP:0002151) | 1.95921145 |
| 123 | Optic disc pallor (HP:0000543) | 1.95892767 |
| 124 | Progressive inability to walk (HP:0002505) | 1.95402021 |
| 125 | Abnormality of macular pigmentation (HP:0008002) | 1.95146423 |
| 126 | Hyperkalemia (HP:0002153) | 1.94271651 |
| 127 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.91424634 |
| 128 | Anencephaly (HP:0002323) | 1.89748763 |
| 129 | Increased hepatocellular lipid droplets (HP:0006565) | 1.88735261 |
| 130 | Stomatitis (HP:0010280) | 1.88379068 |
| 131 | Pachygyria (HP:0001302) | 1.88001669 |
| 132 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.87723371 |
| 133 | Stomach cancer (HP:0012126) | 1.83522292 |
| 134 | Gait imbalance (HP:0002141) | 1.83191670 |
| 135 | Congenital primary aphakia (HP:0007707) | 1.83096200 |
| 136 | Vomiting (HP:0002013) | 1.83093360 |
| 137 | Metabolic acidosis (HP:0001942) | 1.83075509 |
| 138 | Retinal atrophy (HP:0001105) | 1.78157121 |
| 139 | Inability to walk (HP:0002540) | 1.77020521 |
| 140 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75529931 |
| 141 | Dicarboxylic aciduria (HP:0003215) | 1.75529931 |
| 142 | Methylmalonic acidemia (HP:0002912) | 1.73988391 |
| 143 | Paralysis (HP:0003470) | 1.73501431 |
| 144 | Abnormal tarsal ossification (HP:0008369) | 1.73444244 |
| 145 | Postaxial foot polydactyly (HP:0001830) | 1.72864188 |
| 146 | Potter facies (HP:0002009) | 1.72647839 |
| 147 | Facial shape deformation (HP:0011334) | 1.72647839 |
| 148 | Large for gestational age (HP:0001520) | 1.70828570 |
| 149 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.69876811 |
| 150 | Thin bony cortex (HP:0002753) | 1.69758905 |
| 151 | Asplenia (HP:0001746) | 1.69276573 |
| 152 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.67684423 |
| 153 | Hyperammonemia (HP:0001987) | 1.67614488 |
| 154 | Lymphangioma (HP:0100764) | 1.67562102 |
| 155 | Concave nail (HP:0001598) | 1.67369349 |
| 156 | Cerebral edema (HP:0002181) | 1.67055757 |
| 157 | Methylmalonic aciduria (HP:0012120) | 1.66902655 |
| 158 | Delayed CNS myelination (HP:0002188) | 1.66188096 |
| 159 | Abnormality of the costochondral junction (HP:0000919) | 1.65770930 |
| 160 | Focal segmental glomerulosclerosis (HP:0000097) | 1.65384463 |
| 161 | Elevated alkaline phosphatase (HP:0003155) | 1.65167484 |
| 162 | Confusion (HP:0001289) | 1.63081114 |
| 163 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.61036299 |
| 164 | Metaphyseal irregularity (HP:0003025) | 1.60120350 |
| 165 | Axonal loss (HP:0003447) | 1.57988890 |
| 166 | Nausea (HP:0002018) | 1.55400224 |
| 167 | Hypotension (HP:0002615) | 1.55194120 |
| 168 | Malnutrition (HP:0004395) | 1.52341150 |
| 169 | Alveolar cell carcinoma (HP:0006519) | 1.48399299 |
| 170 | Hypophosphatemic rickets (HP:0004912) | 1.48178308 |
| 171 | Lethargy (HP:0001254) | 1.47225780 |
| 172 | Abnormality of the renal cortex (HP:0011035) | 1.47051064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OXSR1 | 8.19986219 |
| 2 | STK39 | 6.63285277 |
| 3 | WNK3 | 5.63557448 |
| 4 | BMPR1B | 3.53396824 |
| 5 | MAP4K2 | 2.86298777 |
| 6 | ZAK | 2.52198565 |
| 7 | NUAK1 | 2.29773898 |
| 8 | TAOK3 | 2.04771110 |
| 9 | WNK4 | 10.5626343 |
| 10 | TLK1 | 1.99176666 |
| 11 | STK38L | 1.86691016 |
| 12 | WNK1 | 1.84667928 |
| 13 | SGK494 | 1.69515765 |
| 14 | SGK223 | 1.69515765 |
| 15 | TGFBR2 | 1.60217722 |
| 16 | ACVR1B | 1.48687351 |
| 17 | MAPK13 | 1.38765130 |
| 18 | PDK2 | 1.36346534 |
| 19 | MAP3K4 | 1.30776724 |
| 20 | SGK2 | 1.28031100 |
| 21 | BCKDK | 1.19890607 |
| 22 | DAPK2 | 1.14577285 |
| 23 | TIE1 | 1.13330296 |
| 24 | PDK4 | 1.09696813 |
| 25 | PDK3 | 1.09696813 |
| 26 | PLK2 | 1.09399738 |
| 27 | MAPKAPK3 | 1.02127854 |
| 28 | SGK3 | 1.01833084 |
| 29 | CDK8 | 1.00574850 |
| 30 | CSNK1G3 | 0.98814295 |
| 31 | CSNK1G1 | 0.98158755 |
| 32 | IKBKB | 0.97948579 |
| 33 | DYRK2 | 0.97798775 |
| 34 | CSNK1A1L | 0.95511778 |
| 35 | MUSK | 0.93816730 |
| 36 | INSRR | 0.90547469 |
| 37 | TRIM28 | 0.89591269 |
| 38 | EIF2AK3 | 0.89479778 |
| 39 | CSNK1G2 | 0.89223651 |
| 40 | CAMKK2 | 0.88468334 |
| 41 | MAP3K14 | 0.80882178 |
| 42 | MST4 | 0.80866962 |
| 43 | MKNK2 | 0.80054521 |
| 44 | BRSK2 | 0.78925734 |
| 45 | STK16 | 0.76282649 |
| 46 | SIK3 | 0.75578516 |
| 47 | ERBB3 | 0.75548334 |
| 48 | STK38 | 0.75382686 |
| 49 | TEC | 0.74278805 |
| 50 | VRK1 | 0.71254742 |
| 51 | VRK2 | 0.70113895 |
| 52 | IRAK1 | 0.69772121 |
| 53 | NEK1 | 0.69330006 |
| 54 | PRKCG | 0.68857779 |
| 55 | KIT | 0.67327593 |
| 56 | NME1 | 0.65262534 |
| 57 | MAP2K7 | 0.65219673 |
| 58 | PINK1 | 0.64176660 |
| 59 | MST1R | 0.63735216 |
| 60 | MAPKAPK5 | 0.59465875 |
| 61 | LIMK1 | 0.59168019 |
| 62 | FLT3 | 0.58783007 |
| 63 | PHKG1 | 0.57356646 |
| 64 | PHKG2 | 0.57356646 |
| 65 | CASK | 0.57023847 |
| 66 | SGK1 | 0.52130297 |
| 67 | RPS6KA5 | 0.51751558 |
| 68 | CSNK1A1 | 0.49900411 |
| 69 | ITK | 0.48734874 |
| 70 | MAP2K6 | 0.46503789 |
| 71 | PLK3 | 0.46004420 |
| 72 | FGFR4 | 0.45110905 |
| 73 | MAP2K2 | 0.44962223 |
| 74 | GSK3A | 0.44677141 |
| 75 | EPHB1 | 0.43913682 |
| 76 | LATS1 | 0.43418682 |
| 77 | EPHA3 | 0.42798928 |
| 78 | EPHB2 | 0.41708816 |
| 79 | MAPK15 | 0.41343354 |
| 80 | NLK | 0.40208621 |
| 81 | STK10 | 0.38978110 |
| 82 | SRPK1 | 0.38310133 |
| 83 | MYLK | 0.37566421 |
| 84 | GRK7 | 0.36740936 |
| 85 | BCR | 0.36541224 |
| 86 | PAK4 | 0.36242542 |
| 87 | PLK4 | 0.35723623 |
| 88 | PIK3CA | 0.34965349 |
| 89 | TNIK | 0.34472095 |
| 90 | CAMK2A | 0.34022457 |
| 91 | SYK | 0.33801794 |
| 92 | EIF2AK2 | 0.33648255 |
| 93 | IRAK3 | 0.33320223 |
| 94 | NEK6 | 0.32807166 |
| 95 | PRKAA2 | 0.32487275 |
| 96 | CAMK1 | 0.31855644 |
| 97 | MKNK1 | 0.31555104 |
| 98 | ABL1 | 0.31400415 |
| 99 | MAPK11 | 0.30032354 |
| 100 | CSNK1D | 0.29148120 |
| 101 | CCNB1 | 0.28881847 |
| 102 | MAP3K7 | 0.28184114 |
| 103 | FER | 0.26386616 |
| 104 | SIK2 | 0.25519364 |
| 105 | DYRK1B | 0.24557238 |
| 106 | TGFBR1 | 0.24368042 |
| 107 | ADRBK2 | 0.24093714 |
| 108 | LRRK2 | 0.24041698 |
| 109 | PRKAA1 | 0.23636675 |
| 110 | MAPK12 | 0.21599933 |
| 111 | MAP3K3 | 0.20818689 |
| 112 | PDPK1 | 0.20342995 |
| 113 | ABL2 | 0.19933356 |
| 114 | AKT3 | 0.19892438 |
| 115 | PRPF4B | 0.19254374 |
| 116 | FRK | 0.17959888 |
| 117 | NEK9 | 0.17545080 |
| 118 | PRKD2 | 0.17072445 |
| 119 | STK3 | 0.17020590 |
| 120 | PKN1 | 0.16435899 |
| 121 | PDK1 | 0.15758481 |
| 122 | MARK3 | 0.14644166 |
| 123 | PIM1 | 0.14575093 |
| 124 | KDR | 0.14362378 |
| 125 | PRKCD | 0.14287238 |
| 126 | PRKCI | 0.13959859 |
| 127 | PTK2B | 0.13136602 |
| 128 | YES1 | 0.13079342 |
| 129 | PTK2 | 0.12001137 |
| 130 | MET | 0.11835110 |
| 131 | STK11 | 0.10060126 |
| 132 | TYK2 | 0.10033603 |
| 133 | PRKCE | 0.09836456 |
| 134 | PRKCZ | 0.09622054 |
| 135 | TXK | 0.08614228 |
| 136 | GRK1 | 0.07883301 |
| 137 | CHUK | 0.06735184 |
| 138 | GRK6 | 0.06664459 |
| 139 | JAK2 | 0.06171816 |
| 140 | PRKACA | 0.06168009 |
| 141 | PRKACG | 0.06167329 |
| 142 | PRKCA | 0.05432216 |
| 143 | EPHA4 | 0.05341928 |
| 144 | IGF1R | 0.04767165 |
| 145 | BMPR2 | 0.04691856 |
| 146 | CAMK4 | 0.04130885 |
| 147 | IKBKE | 0.02643860 |
| 148 | BLK | 0.02589622 |
| 149 | PRKCQ | 0.02570600 |
| 150 | PRKCH | 0.02334779 |
| 151 | CSK | 0.02296829 |
| 152 | MAPK7 | 0.02156735 |
| 153 | INSR | 0.02071108 |
| 154 | MAP3K13 | 0.02005800 |
| 155 | ROCK1 | 0.01763815 |
| 156 | TAOK2 | 0.01499983 |
| 157 | MAP3K12 | 0.01340136 |
| 158 | PAK3 | 0.00903678 |
| 159 | TNK2 | 0.00774153 |
| 160 | ADRBK1 | 0.00769323 |
| 161 | SRC | 0.00552016 |
| 162 | GRK5 | 0.00189096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.59354283 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.48931288 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.46966481 |
| 4 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.45858538 |
| 5 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.22653284 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.12416433 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.09742864 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.04195048 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.00233026 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.86631557 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.78076108 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.63333220 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.53769433 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.43781237 |
| 15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.42635982 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.36045890 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.12725806 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12494807 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.11713500 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.10228293 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.05149001 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.01339881 |
| 23 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.99342523 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.93383873 |
| 25 | RNA polymerase_Homo sapiens_hsa03020 | 1.85902273 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.79263933 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79237284 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.78411047 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78304924 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.77380140 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75401431 |
| 32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.71043827 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.68825941 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.67707205 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66375563 |
| 36 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.62975571 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.55247384 |
| 38 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.55057905 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.53626327 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.50719730 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50166442 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49785996 |
| 43 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.47680760 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.43762603 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.41309859 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.38659881 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.36935839 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36335533 |
| 49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34989906 |
| 50 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32560800 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 1.32539947 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.29520351 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29496829 |
| 54 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28792553 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.28584266 |
| 56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27904574 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26299551 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.20000803 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.16383220 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13009299 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 1.11898260 |
| 62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11508768 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.07862584 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.05262765 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04603842 |
| 66 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96707676 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.95362127 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94208622 |
| 69 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92326956 |
| 70 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.91406772 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91405237 |
| 72 | Purine metabolism_Homo sapiens_hsa00230 | 0.89196019 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86021941 |
| 74 | Lysosome_Homo sapiens_hsa04142 | 0.85711943 |
| 75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85494639 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83677870 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81749851 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81310533 |
| 79 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81084578 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79137338 |
| 81 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77094206 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77065172 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.75698260 |
| 84 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74422091 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73009391 |
| 86 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71694623 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68346209 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66651903 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66580908 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65540937 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63696781 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63193936 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62977146 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61152510 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60306550 |
| 96 | Ribosome_Homo sapiens_hsa03010 | 0.59614152 |
| 97 | Taste transduction_Homo sapiens_hsa04742 | 0.58871105 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58695762 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.57249615 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.56722590 |
| 101 | GABAergic synapse_Homo sapiens_hsa04727 | 0.52402745 |
| 102 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51959912 |
| 103 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.51340666 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50468585 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50132942 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49225553 |
| 107 | Base excision repair_Homo sapiens_hsa03410 | 0.47151833 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46989042 |
| 109 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.46803082 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46075980 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.45201272 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42462024 |
| 113 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42442407 |
| 114 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.41790442 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40274422 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37691762 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35795790 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.35778476 |
| 119 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32132871 |
| 120 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32047860 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30605922 |
| 122 | ABC transporters_Homo sapiens_hsa02010 | 0.30207484 |
| 123 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.30075490 |
| 124 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.29038841 |
| 125 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25660303 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.25133661 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.21772583 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21543611 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.18612122 |
| 130 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.18542613 |
| 131 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17098508 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.15787541 |
| 133 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14968498 |
| 134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.14367597 |
| 135 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.10809551 |
| 136 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09413324 |
| 137 | Parkinsons disease_Homo sapiens_hsa05012 | 0.08980719 |
| 138 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08095192 |
| 139 | Hepatitis C_Homo sapiens_hsa05160 | 0.06834637 |
| 140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.06309872 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05828225 |
| 142 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.04321890 |
| 143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.03502290 |
| 144 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.00550205 |
| 145 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.00469771 |
| 146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0624696 |
| 147 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0477893 |
| 148 | Bladder cancer_Homo sapiens_hsa05219 | -0.0285412 |
| 149 | Tuberculosis_Homo sapiens_hsa05152 | -0.0192949 |
| 150 | Melanoma_Homo sapiens_hsa05218 | -0.0117114 |

